• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Ovarian stimulation in the luteal phase: systematic review and meta-analysis.黄体期卵巢刺激:系统评价与荟萃分析。
J Assist Reprod Genet. 2016 Aug;33(8):971-80. doi: 10.1007/s10815-016-0721-5. Epub 2016 May 4.
2
Interventions for fertility preservation in women with cancer undergoing chemotherapy.对接受化疗的癌症女性进行生育力保存的干预措施。
Cochrane Database Syst Rev. 2025 Jun 19;6:CD012891. doi: 10.1002/14651858.CD012891.pub2.
3
Oral medications including clomiphene citrate or aromatase inhibitors with gonadotropins for controlled ovarian stimulation in women undergoing in vitro fertilisation.口服药物,包括枸橼酸氯米芬或芳香化酶抑制剂与促性腺激素联合用于接受体外受精的女性的控制性卵巢刺激。
Cochrane Database Syst Rev. 2017 Nov 2;11(11):CD008528. doi: 10.1002/14651858.CD008528.pub3.
4
Gonadotropin-releasing hormone agonist protocols for pituitary suppression in assisted reproduction.辅助生殖中用于垂体抑制的促性腺激素释放激素激动剂方案。
Cochrane Database Syst Rev. 2025 Jan 9;1(1):CD006919. doi: 10.1002/14651858.CD006919.pub5.
5
Cycle regimens for frozen-thawed embryo transfer.冻融胚胎移植的周期方案。
Cochrane Database Syst Rev. 2017 Jul 5;7(7):CD003414. doi: 10.1002/14651858.CD003414.pub3.
6
Individualised gonadotropin dose selection using markers of ovarian reserve for women undergoing in vitro fertilisation plus intracytoplasmic sperm injection (IVF/ICSI).针对接受体外受精加卵胞浆内单精子注射(IVF/ICSI)的女性,使用卵巢储备标志物进行个性化促性腺激素剂量选择。
Cochrane Database Syst Rev. 2018 Feb 1;2(2):CD012693. doi: 10.1002/14651858.CD012693.pub2.
7
Random Start Ovarian Stimulation for Oocyte or Embryo Cryopreservation in Women Desiring Fertility Preservation Prior to Gonadotoxic Cancer Therapy.随机启动卵巢刺激用于在性腺毒性癌症治疗前希望保留生育能力的女性的卵母细胞或胚胎冷冻保存。
Curr Pharm Biotechnol. 2017 Nov 10;18(8):609-613. doi: 10.2174/1389201018666170808122531.
8
The safety and efficacy of controlled ovarian hyperstimulation for fertility preservation in women with early breast cancer: a systematic review.早期乳腺癌女性生育力保存中控制性卵巢过度刺激的安全性和有效性:一项系统评价
Hum Reprod. 2017 May 1;32(5):1033-1045. doi: 10.1093/humrep/dex027.
9
Gonadotrophin-releasing hormone agonist protocols for pituitary suppression in assisted reproduction.辅助生殖中用于垂体抑制的促性腺激素释放激素激动剂方案。
Cochrane Database Syst Rev. 2011 Aug 10(8):CD006919. doi: 10.1002/14651858.CD006919.pub3.
10
Luteal phase support for assisted reproduction cycles.辅助生殖周期的黄体期支持。
Cochrane Database Syst Rev. 2011 Oct 5(10):CD009154. doi: 10.1002/14651858.CD009154.pub2.

引用本文的文献

1
Pregnancy after breast cancer: latest evidence and practical considerations.乳腺癌后的妊娠:最新证据与实际考量
Ther Adv Med Oncol. 2025 Jun 18;17:17588359251346648. doi: 10.1177/17588359251346648. eCollection 2025.
2
How to Preserve Fertility in Reproductive-Age Women with Cancer.如何在癌症生育年龄女性中保留生育能力。
J Clin Med. 2025 Mar 12;14(6):1912. doi: 10.3390/jcm14061912.
3
Smaller follicle diameter improves outcomes in natural LPOS: a retrospective cohort study.较小的卵泡直径可改善自然周期腹腔镜卵巢打孔术的结局:一项回顾性队列研究。
J Assist Reprod Genet. 2025 Apr;42(4):1287-1295. doi: 10.1007/s10815-025-03421-9. Epub 2025 Feb 11.
4
Patients with gynecological malignancies are similar to other IVF patients without cancer for clinical and molecular reproductive parameters and DNA damage response pattern.对于临床和分子生殖参数以及DNA损伤反应模式而言,妇科恶性肿瘤患者与其他无癌症的体外受精患者相似。
Sci Rep. 2024 Jun 13;14(1):13628. doi: 10.1038/s41598-024-64403-y.
5
Current Position of Oncofertility in Adolescent Female Cancer Patients: A Comparative Review on Society Guidelines.青少年女性癌症患者的生育力保存现状:社会指南的比较综述。
In Vivo. 2024 Jan-Feb;38(1):48-57. doi: 10.21873/invivo.13409.
6
Retrospective study of influencing factors on the outcomes of luteal phase stimulation in patients with dual stimulation.回顾性研究双刺激患者黄体期刺激结局的影响因素。
PeerJ. 2023 May 5;11:e15296. doi: 10.7717/peerj.15296. eCollection 2023.
7
Clinical Application of Double Ovulation Stimulation in Patients with Diminished Ovarian Reserve and Asynchronous Follicular Development Undergoing Assisted Reproduction Technology.双重促排卵在卵巢储备功能减退及卵泡发育不同步的辅助生殖技术患者中的临床应用
Curr Med Sci. 2023 Apr;43(2):304-312. doi: 10.1007/s11596-022-2687-0. Epub 2023 Mar 13.
8
Effect of ovarian growth factors on ultra-structural maturation in frozen human immature oocytes after in vitro maturation: a comparative study.卵巢生长因子对体外成熟后冷冻人未成熟卵母细胞超微结构成熟的影响:一项对比研究。
Reprod Health. 2022 Dec 1;19(1):215. doi: 10.1186/s12978-022-01521-8.
9
A Feasible Option before Cycle Cancellation for Poor Responders; STOP-START Protocol.对于反应不良者,在取消周期前的一个可行选择;停止-启动方案。
Int J Fertil Steril. 2021 Oct;15(4):300-302. doi: 10.22074/IJFS.2021.13462. Epub 2021 Oct 16.
10
ART outcomes following ovarian stimulation in the luteal phase:a systematic review and meta-analysis.黄体期卵巢刺激后的 ART 结局:系统评价和荟萃分析。
J Assist Reprod Genet. 2021 Aug;38(8):1927-1938. doi: 10.1007/s10815-021-02237-7. Epub 2021 May 25.

本文引用的文献

1
Ovarian stimulation for emergency fertility preservation in cancer patients: A case series study.
Gynecol Oncol Rep. 2014 Oct 1;10:19-21. doi: 10.1016/j.gore.2014.08.002. eCollection 2014 Dec.
2
Variability in the practice of fertility preservation for patients with cancer.癌症患者生育力保存实践中的差异。
PLoS One. 2015 May 26;10(5):e0127335. doi: 10.1371/journal.pone.0127335. eCollection 2015.
3
Efficacy of random-start controlled ovarian stimulation in cancer patients.随机起始控制性卵巢刺激对癌症患者的疗效。
J Korean Med Sci. 2015 Mar;30(3):290-5. doi: 10.3346/jkms.2015.30.3.290. Epub 2015 Feb 16.
4
Double stimulations during the follicular and luteal phases of poor responders in IVF/ICSI programmes (Shanghai protocol).体外受精/卵胞浆内单精子注射方案(上海方案)中反应不良者卵泡期和黄体期的双重刺激。
Reprod Biomed Online. 2014 Dec;29(6):684-91. doi: 10.1016/j.rbmo.2014.08.009. Epub 2014 Sep 6.
5
Random-start controlled ovarian hyperstimulation with letrozole for fertility preservation in cancer patients: case series and review of literature.来曲唑随机起始控制性卵巢刺激用于癌症患者生育力保存:病例系列及文献综述
J Pak Med Assoc. 2014 Jul;64(7):830-2.
6
Comparison of starting ovarian stimulation on day 2 versus day 15 of the menstrual cycle in the same oocyte donor and pregnancy rates among the corresponding recipients of vitrified oocytes.比较同一卵母细胞供体在月经周期第 2 天和第 15 天开始卵巢刺激的效果,以及相应的玻璃化卵母细胞受者的妊娠率。
Fertil Steril. 2014 Nov;102(5):1307-11. doi: 10.1016/j.fertnstert.2014.07.741. Epub 2014 Aug 22.
7
Luteal-phase ovarian stimulation is feasible for producing competent oocytes in women undergoing in vitro fertilization/intracytoplasmic sperm injection treatment, with optimal pregnancy outcomes in frozen-thawed embryo transfer cycles.黄体期卵巢刺激对于接受体外受精/胞浆内单精子注射治疗的女性来说是可行的,可产生有活力的卵子,并且在冷冻胚胎移植周期中获得最佳的妊娠结局。
Fertil Steril. 2014 Jan;101(1):105-11. doi: 10.1016/j.fertnstert.2013.09.007. Epub 2013 Oct 23.
8
Fertility preservation in patients undergoing gonadotoxic therapy or gonadectomy: a committee opinion.行性腺毒性治疗或性腺切除术患者的生育力保存:委员会意见。
Fertil Steril. 2013 Nov;100(5):1214-23. doi: 10.1016/j.fertnstert.2013.08.012. Epub 2013 Sep 5.
9
Effective method for emergency fertility preservation: random-start controlled ovarian stimulation.有效的紧急生育力保存方法:随机起始控制性卵巢刺激。
Fertil Steril. 2013 Dec;100(6):1673-80. doi: 10.1016/j.fertnstert.2013.07.1992. Epub 2013 Aug 26.
10
Fertility preservation for patients with cancer: American Society of Clinical Oncology clinical practice guideline update.癌症患者的生育力保存:美国临床肿瘤学会临床实践指南更新。
J Clin Oncol. 2013 Jul 1;31(19):2500-10. doi: 10.1200/JCO.2013.49.2678. Epub 2013 May 28.

黄体期卵巢刺激:系统评价与荟萃分析。

Ovarian stimulation in the luteal phase: systematic review and meta-analysis.

作者信息

Boots C E, Meister M, Cooper A R, Hardi A, Jungheim E S

机构信息

Obstetrics & Gynecology, Washington University, 4444 Forest Park, Suite 3100, St. Louis, MO, 63108, USA.

Washington University, 660 Euclid Avenue, St. Louis, MO, 63110, USA.

出版信息

J Assist Reprod Genet. 2016 Aug;33(8):971-80. doi: 10.1007/s10815-016-0721-5. Epub 2016 May 4.

DOI:10.1007/s10815-016-0721-5
PMID:27146151
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4974222/
Abstract

PURPOSE

The purpose of this study was to evaluate whether outcomes are different if controlled ovarian stimulation (COS) is started in the luteal phase rather than the follicular phase.

METHODS

A systematic review and meta-analysis was performed. Sixteen studies were included in the qualitative analysis, and eight studies with a total of 338 women were included in the quantitative analysis.

RESULTS

Cycles initiated in the luteal phase were slightly longer (WMD 1.1 days, 95 % CI 0.39-1.9) and utilized more total gonadotropins (WMD 817 IU, 95 % CI 489-1144). However, no differences were noted in peak estradiol levels (WMD -411 pg/ml, 95 % CI -906-84.7) or in the total number of oocytes retrieved (WMD 0.52 oocytes, 95 % CI -0.74-1.7). There were slightly more mature oocytes retrieved in the luteal phase (WMD 0.77 oocytes, 95 % CI 0.21-1.3), and fertilization rates were significantly higher (WMD 10 %, 95 % CI 0.03-0.18). While only three studies reported pregnancy outcomes, no difference was noted in the FET pregnancy rates after COS in the luteal versus follicular phase (RR 0.95, 95 % CI 0.56-1.7). A post hoc power analysis revealed that a sample of this size was sufficient to detect a clinically meaningful difference of 2 oocytes retrieved with 93 % power.

CONCLUSION

Although initiating COS in the luteal phase requires a longer stimulation and a higher dose of total gonadotropin, these differences are not clinically significant. Furthermore, COS initiated in the luteal phase does not compromise the quantity or quality of oocytes retrieved compared to outcomes of traditional stimulation in the follicular phase.

摘要

目的

本研究旨在评估在黄体期而非卵泡期开始进行控制性卵巢刺激(COS)时,结局是否有所不同。

方法

进行了一项系统评价和荟萃分析。定性分析纳入了16项研究,定量分析纳入了8项研究,共338名女性。

结果

在黄体期开始的周期略长(加权均数差[WMD] 1.1天,95%可信区间[CI] 0.39 - 1.9),且使用的促性腺激素总量更多(WMD 817国际单位,95% CI 489 - 1144)。然而,在雌二醇峰值水平(WMD -411皮克/毫升,95% CI -906 - 84.7)或获取的卵母细胞总数(WMD 0.52个卵母细胞,95% CI -0.74 - 1.7)方面未观察到差异。在黄体期获取的成熟卵母细胞略多(WMD 0.77个卵母细胞,95% CI 0.21 - 1.3),且受精率显著更高(WMD 10%,95% CI 0.03 - 0.18)。虽然只有三项研究报告了妊娠结局,但在黄体期与卵泡期进行COS后的冻融胚胎移植妊娠率方面未观察到差异(风险比[RR] 0.95,95% CI 0.56 - 1.7)。事后效能分析显示,该样本量足以以93%的效能检测到获取的卵母细胞有2个的临床有意义差异。

结论

尽管在黄体期开始进行COS需要更长的刺激时间和更高剂量的促性腺激素总量,但这些差异在临床上并不显著。此外,与传统卵泡期刺激的结局相比,在黄体期开始进行COS不会损害获取的卵母细胞数量或质量。